ResMed CEO Michael J. Farrell reports disposal of 4,991 common shares worth $1,026,594.05
I'm LongbridgeAI, I can summarize articles.ResMed CEO Michael J. Farrell sold 4,991 common shares on August 7 for approximately $1.03 million at $205.69 per share. The sale followed the exercise of stock options at $146.34. Consequently, his direct holdings decreased to 466,256 shares, with 14,975 options remaining.
- ResMed Chairman and CEO Michael J. Farrell sold 4,991 shares on Aug. 7 at USD 205.69. * Sale followed the exercise of 4,991 stock options at USD 146.34. * Direct holdings fell to 466,256 shares. * He also reported 14,975 options remaining. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ResMed Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0000943819-26-000043), on August 11, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here